$1.76
-0.03-1.63%
At Close: -
$1.85
0.095.07%
After Hours: 8:36 AM EDT
15 minutes delayed
Revelation Biosciences
REVBNASDAQ
Revelation Biosciences (REVB) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestRevelation Biosciences (NASDAQ:REVB) Stock Quotes, Forecast and News Summary
Revelation Biosciences Stock (NASDAQ: REVB) stock price, news, charts, stock research, profile.
| Open | $1.84 |
| Close | $1.76 |
| Volume / Avg. | 107.18K / 607.93K |
| Day Range | 1.74 - 1.92 |
| 52 Wk Range | 1.61 - 28.98 |
| Market Cap | $3.02M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 38 |
| Short Interest | 2.27% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Revelation Biosciences Inc
Sector
Health Care
Industry
Biotechnology
Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of t...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Revelation Biosciences (REVB) stock?
You can purchase shares of Revelation Biosciences (NASDAQ:REVB) through any online brokerage.
Who are Revelation Biosciences (REVB) competitors?
Other companies in Revelation Biosciences’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Entero Therapeutics (NASDAQ:ENTO), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
What is the target price for Revelation Biosciences (REVB) stock?
There is no analysis for Revelation Biosciences.
What is the forecast for Revelation Biosciences (REVB) stock?
Revelation Biosciences has a consensus price target of $13.50.
Current stock price for Revelation Biosciences (REVB)?
The stock price for Revelation Biosciences (NASDAQ: REVB) is $1.85 last updated Today at July 3, 2024 at 8:36 AM EDT.
Does Revelation Biosciences (REVB) pay a dividend?
There are no upcoming dividends for Revelation Biosciences.
When is Revelation Biosciences (NASDAQ:REVB) reporting earnings?
Revelation Biosciences’s Q2 earnings are confirmed for Friday, August 9, 2024.
Is Revelation Biosciences (REVB) going to split?
There is no upcoming split for Revelation Biosciences.
What sector and industry does Revelation Biosciences (REVB) operate in?
Revelation Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.